Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Multifocal IOLs in radial keratotomy eyes: 10 year follow-up

Poster Details

First Author: A.Gulani USA

Co Author(s):                  

Abstract Details


To evaluate the efficacy and visual outcomes of ReStor multifocal IOLs in patients with previous RK surgery presenting with cataracts, hyperopia, astigmatism and presbyopia.


Gulani Vision Institute


9 eyes of 5 patients having previously undergone RK surgery underwent a planned Stage I- ReStor IOL placement after phacoemulsification for cataract extraction and correction of hyperopia and presbyopia to be followed by Stage II- Excimer PRK (Photo Refractive Keratectomy) to correct the astigmatism, irregular anterior surface contour and widen the effective anterior corneal optical zone. 7 out of 9 eyes underwent the planned stage two of PRK surgery while two eyes of one patient did not since that patient was very satisfied with his vision with stage one itself.


100% of patients experienced an objective improvement in unaided vision to 20/25 OU for distance and 20/25 for near. They all noted improved night time glare and driving confidence. This result has been stable with a follow range of 1-10years


With a resurgence of patients having undergone previous radial keratotomy (RK) and now presenting at a cataract age, we need to be ready for what could be a refractive epidemic of patients having undergone previous refractive surgery who are now looking for surgical options to restore their independence with excellent, unaided vision for distance and near once again.

Financial Disclosure:


Back to Poster listing